"Maintain Your Brain" study shows how a tailored online program can improve cognition and lower dementia risk—discover how simple lifestyle changes could protect your brain as you age.
SaveHealth provides an overview of Alzheimer's disease, including treatment and coping mechanisms for those with the disease ...
Antimicrobials, vaccines, and anti-inflammatories associated with reduced risk for Alzheimer disease and dementia.
A pathway once considered fundamental in Alzheimer’s disease is being studied intensely again, and may soon result in safer, ...
The Food and Drug Administration (FDA) has approved a new maintenance dosing schedule for Leqembi, a monoclonal antibody ...
Lecanemab is a humanized immunoglobulin gamma 1 monoclonal antibody directed against aggregated soluble and insoluble forms of amyloid beta.
Access to the new Alzheimer's drugs is limited by strict eligibility criteria, long wait times, and a lack of infusion ...
The FDA approves a new maintenance dosing regimen for lecanemab (Leqembi; Eisai) in patients with early-stage Alzheimer ...
Taking too long to enter the phase of sleep in which we dream may be an early sign of Alzheimer's disease. This is the ...
There are two kinds of risk factors for dementia: non-modifiable and modifiable. Non-modifiable risk factors are ones that cannot be changed or eliminated, like aging, family history and genetics.
Dr. Anelyssa D'Abreu, an associate professor of neurology in UVA's School of Medicine who specializes in geriatric neurology, ...
As part of the regulatory action, memantine/donepezil extended-release capsules have been granted a 180-day exclusivity in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback